review article | Q7318358 |
scholarly article | Q13442814 |
P356 | DOI | 10.1007/5584_2016_32 |
P698 | PubMed publication ID | 27311318 |
P50 | author | Yoshiaki Furukawa | Q57339180 |
Eiichi Tokuda | Q84352374 | ||
P2860 | cites work | Ataxin-2 intermediate-length polyglutamine expansions are associated with increased risk for ALS | Q24297462 |
Rules for nuclear localization sequence recognition by karyopherin beta 2 | Q24600321 | ||
Evaluating the role of the FUS/TLS-related gene EWSR1 in amyotrophic lateral sclerosis | Q24605104 | ||
Mutations in prion-like domains in hnRNPA2B1 and hnRNPA1 cause multisystem proteinopathy and ALS | Q24629495 | ||
ALS-associated fused in sarcoma (FUS) mutations disrupt Transportin-mediated nuclear import | Q24630100 | ||
A new subtype of frontotemporal lobar degeneration with FUS pathology | Q24647697 | ||
Structural and energetic basis of ALS-causing mutations in the atypical proline–tyrosine nuclear localization signal of the Fused in Sarcoma protein (FUS) | Q27670694 | ||
Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis | Q28131672 | ||
Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis | Q28131805 | ||
Human 75-kDa DNA-pairing protein is identical to the pro-oncoprotein TLS/FUS and is able to promote D-loop formation | Q28138179 | ||
Identification of an RNA binding specificity for the potential splicing factor TLS | Q28138875 | ||
Human POMp75 is identified as the pro-oncoprotein TLS/FUS: both POMp75 and POMp100 DNA homologous pairing activities are associated to cell proliferation | Q28141846 | ||
Mutations in the FUS/TLS gene on chromosome 16 cause familial amyotrophic lateral sclerosis | Q28236796 | ||
Mutations in FUS, an RNA processing protein, cause familial amyotrophic lateral sclerosis type 6 | Q28236805 | ||
RNA granules: post-transcriptional and epigenetic modulators of gene expression | Q28245899 | ||
TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis | Q28270779 | ||
TDP-43 and FUS in amyotrophic lateral sclerosis and frontotemporal dementia | Q28294001 | ||
Aberrant localization of FUS and TDP43 is associated with misfolding of SOD1 in amyotrophic lateral sclerosis | Q28730723 | ||
Cell-free formation of RNA granules: low complexity sequence domains form dynamic fibers within hydrogels | Q29614781 | ||
Mutations of optineurin in amyotrophic lateral sclerosis | Q29614836 | ||
TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis | Q29615597 | ||
TARDBP mutations in individuals with sporadic and familial amyotrophic lateral sclerosis | Q29616311 | ||
RNA seeds higher-order assembly of FUS protein | Q30457170 | ||
Biochemical Properties and Biological Functions of FET Proteins | Q30459373 | ||
FUS/TLS assembles into stress granules and is a prosurvival factor during hyperosmolar stress | Q30577079 | ||
Phosphorylation-regulated binding of RNA polymerase II to fibrous polymers of low-complexity domains | Q30577537 | ||
The multifunctional FUS, EWS and TAF15 proto-oncoproteins show cell type-specific expression patterns and involvement in cell spreading and stress response | Q33351073 | ||
Molecular determinants and genetic modifiers of aggregation and toxicity for the ALS disease protein FUS/TLS | Q33889532 | ||
FUS immunogold labeling TEM analysis of the neuronal cytoplasmic inclusions of neuronal intermediate filament inclusion disease: a frontotemporal lobar degeneration with FUS proteinopathy | Q33908722 | ||
Glutamine repeats and neurodegeneration | Q33938576 | ||
The TET family of proteins: functions and roles in disease | Q33999337 | ||
Nomenclature and nosology for neuropathologic subtypes of frontotemporal lobar degeneration: an update | Q34020227 | ||
FET proteins TAF15 and EWS are selective markers that distinguish FTLD with FUS pathology from amyotrophic lateral sclerosis with FUS mutations | Q34209561 | ||
Mutant FUS proteins that cause amyotrophic lateral sclerosis incorporate into stress granules | Q34308339 | ||
A frameshift deletion in peripherin gene associated with amyotrophic lateral sclerosis | Q34342425 | ||
Male sterility and enhanced radiation sensitivity in TLS(-/-) mice | Q34662602 | ||
Tyrosine Phosphorylation in the C-Terminal Nuclear Localization and Retention Signal (C-NLS) of the EWS Protein | Q35013235 | ||
A comparative clinical, pathological, biochemical and genetic study of fused in sarcoma proteinopathies | Q35206942 | ||
A yeast functional screen predicts new candidate ALS disease genes | Q35641365 | ||
Emerging principles of conformation-based prion inheritance | Q35799989 | ||
Pathological heterogeneity in amyotrophic lateral sclerosis with FUS mutations: two distinct patterns correlating with disease severity and mutation | Q35869162 | ||
Monomethylated and unmethylated FUS exhibit increased binding to Transportin and distinguish FTLD-FUS from ALS-FUS. | Q35928701 | ||
ALS/FTD Mutation-Induced Phase Transition of FUS Liquid Droplets and Reversible Hydrogels into Irreversible Hydrogels Impairs RNP Granule Function | Q36320469 | ||
Arginine methylation next to the PY-NLS modulates Transportin binding and nuclear import of FUS. | Q36408540 | ||
The RRM domain of human fused in sarcoma protein reveals a non-canonical nucleic acid binding site. | Q36501107 | ||
TARDBP mutations in amyotrophic lateral sclerosis with TDP-43 neuropathology: a genetic and histopathological analysis | Q36536399 | ||
ALS-associated mutant FUS induces selective motor neuron degeneration through toxic gain of function | Q36548825 | ||
Divergent roles of ALS-linked proteins FUS/TLS and TDP-43 intersect in processing long pre-mRNAs | Q36650975 | ||
Sarcomas: genetics, signalling, and cellular origins. Part 1: The fellowship of TET. | Q36906766 | ||
Transgenics, toxicity and therapeutics in rodent models of mutant SOD1-mediated familial ALS. | Q37087752 | ||
TDP-43 A315T mutation in familial motor neuron disease | Q37354490 | ||
RNA-binding proteins with prion-like domains in ALS and FTLD-U. | Q37918720 | ||
The changing scene of amyotrophic lateral sclerosis | Q38086771 | ||
Intranuclear aggregation of mutant FUS/TLS as a molecular pathomechanism of amyotrophic lateral sclerosis | Q39054098 | ||
Ataxin-2 interacts with FUS and intermediate-length polyglutamine expansions enhance FUS-related pathology in amyotrophic lateral sclerosis | Q39240882 | ||
The seeds of neurodegeneration: prion-like spreading in ALS | Q39247056 | ||
Cell-free formation of RNA granules: bound RNAs identify features and components of cellular assemblies. | Q39349822 | ||
Identification and characterization of FUS/TLS as a new target of ATM. | Q39962311 | ||
RNA-binding protein TLS is a major nuclear aggregate-interacting protein in huntingtin exon 1 with expanded polyglutamine-expressing cells | Q40028993 | ||
Inclusions in frontotemporal lobar degeneration with TDP-43 proteinopathy (FTLD-TDP) and amyotrophic lateral sclerosis (ALS), but not FTLD with FUS proteinopathy (FTLD-FUS), have properties of amyloid. | Q41341998 | ||
Interaction of FUS and HDAC1 regulates DNA damage response and repair in neurons. | Q41469956 | ||
Widespread binding of FUS along nascent RNA regulates alternative splicing in the brain | Q41955381 | ||
Position-dependent FUS-RNA interactions regulate alternative splicing events and transcriptions | Q42246467 | ||
Expression and subcellular localization of Ewing sarcoma (EWS) protein is affected by the methylation process | Q44547089 | ||
Huntingtin-encoded polyglutamine expansions form amyloid-like protein aggregates in vitro and in vivo | Q45294913 | ||
The RNA-binding protein FUS/TLS is a common aggregate-interacting protein in polyglutamine diseases | Q45295489 | ||
The RNA binding protein TLS is translocated to dendritic spines by mGluR5 activation and regulates spine morphology. | Q46409672 | ||
Transportin 1 accumulates specifically with FET proteins but no other transportin cargos in FTLD-FUS and is absent in FUS inclusions in ALS with FUS mutations | Q46624207 | ||
Transportin 1 accumulates in FUS inclusions in adult-onset ALS without FUS mutation | Q48187879 | ||
FUS-immunoreactive intranuclear inclusions in neurodegenerative disease. | Q48433435 | ||
Identification of a tripartite import signal in the Ewing Sarcoma protein (EWS) | Q57931910 | ||
P407 | language of work or name | English | Q1860 |
P921 | main subject | amyotrophic lateral sclerosis | Q206901 |
P304 | page(s) | 1-12 | |
P577 | publication date | 2016-06-17 | |
P1433 | published in | Advances in Experimental Medicine and Biology | Q4686385 |
P1476 | title | Aggregation of FET Proteins as a Pathological Change in Amyotrophic Lateral Sclerosis | |
P478 | volume | 925 |
Q47693846 | The roles of intrinsic disorder-based liquid-liquid phase transitions in the "Dr. Jekyll-Mr. Hyde" behavior of proteins involved in amyotrophic lateral sclerosis and frontotemporal lobar degeneration | cites work | P2860 |